scholarly article | Q13442814 |
P50 | author | Anne Ulrich | Q4768858 |
Sandro Keller | Q42323003 | ||
Jessie Yu | Q42421388 | ||
Marina Rautenbach | Q42421399 | ||
Robert E. W. Hancock | Q53441913 | ||
Kai Hilpert | Q54087374 | ||
Jochen Bürck | Q56934830 | ||
Serge Ruden | Q125317905 | ||
P2093 | author name string | Claudia Muhle-Goll | |
Melissa R Elliott | |||
Brett McLeod | |||
P2860 | cites work | Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria | Q24550625 |
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
High-throughput generation of small antibacterial peptides with improved activity | Q33220258 | ||
The co-evolution of host cationic antimicrobial peptides and microbial resistance | Q36508686 | ||
Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. | Q36740138 | ||
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria | Q37014658 | ||
Salt-resistant alpha-helical cationic antimicrobial peptides. | Q39471096 | ||
Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli | Q39653098 | ||
The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding | Q43547658 | ||
Interaction of cationic antimicrobial peptides with model membranes | Q43687963 | ||
Sequence Requirements and an Optimization Strategy for Short Antimicrobial Peptides | Q57957132 | ||
Mechanism of antimicrobial action of indolicidin | Q74291604 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antimicrobial peptide | Q1201508 |
P1104 | number of pages | 4 | |
P304 | page(s) | 4480-4483 | |
P577 | publication date | 2010-07-26 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Short cationic antimicrobial peptides interact with ATP. | |
P478 | volume | 54 |
Q40116933 | A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP. |
Q33782009 | Additive and synergistic membrane permeabilization by antimicrobial (lipo)peptides and detergents |
Q39410548 | Antibacterial Mode of Action of Ib-AMP1 Against Escherichia coli O157:H7. |
Q58693719 | Antimicrobial Activity of NCR Plant Peptides Strongly Depends on the Test Assays |
Q36784571 | Antimicrobial metallopeptides with broad nuclease and ribonuclease activity |
Q55982720 | Antimicrobial peptides |
Q90732470 | BioSAXS Measurements Reveal That Two Antimicrobial Peptides Induce Similar Molecular Changes in Gram-Negative and Gram-Positive Bacteria |
Q28539079 | Broad-spectrum anti-biofilm peptide that targets a cellular stress response |
Q42102649 | Comparative Analysis of the Bacterial Membrane Disruption Effect of Two Natural Plant Antimicrobial Peptides |
Q34809662 | Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications |
Q41147373 | Hydrophobic mismatch demonstrated for membranolytic peptides, and their use as molecular rulers to measure bilayer thickness in native cells |
Q35925429 | Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity. |
Q37909413 | Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs. |
Q92538088 | Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions |
Q47424532 | Membrane Cholesterol Reduces Polymyxin B Nephrotoxicity in Renal Membrane Analogs |
Q28533779 | Putative bioactive motif of tritrpticin revealed by an antibody with biological receptor-like properties |
Q39265769 | Screening and Optimizing Antimicrobial Peptides by Using SPOT-Synthesis. |
Q33690395 | Screening for antifungal peptides and their modes of action in Aspergillus nidulans |
Q26861137 | Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides |
Q92071604 | Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa |
Q34616362 | Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. |
Q54303879 | The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability. |
Q35666408 | Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B. |
Search more.